|
Jul 8
|
3 Dividend Stocks Crushing the S&P 500 With 30%+ Annual Total Returns
|
|
Jul 8
|
Beat the Market Like Zacks: Carvana, Adobe, Amgen in Focus
|
|
Jun 27
|
Can Amgen Stock Keep Trouncing the S&P 500?
|
|
Jun 26
|
Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst
|
|
Jun 26
|
The Zacks Analyst Blog Highlights Chevron, Amgen, Philip Morris, Hurco and Perma-Pipe
|
|
Jun 26
|
Pharma M&A: The top high value deals in 2023
|
|
Jun 25
|
Top Stock Reports for Chevron, Amgen & Philip Morris
|
|
Jun 25
|
BMS expands Krazati’s FDA label to include colorectal cancer
|
|
Jun 25
|
Biotech ETF (BBH) Hits New 52-Week High
|
|
Jun 21
|
The 30-stock secret: ‘Don’t fight Papa Dow’
|
|
Jun 12
|
Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
|
|
Jun 12
|
AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024
|
|
Jun 12
|
Amgen (AMGN) Stock Fell After Some Concerns Regarding The Released Clinical Data
|
|
Jun 11
|
Is Amgen Inc (NASDAQ:AMGN) the Top Dividend Stock to Buy in 2024?
|
|
Jun 10
|
Beat the Market Like Zacks: Goldman Sachs, Micron, Amgen in Focus
|
|
Jun 7
|
Why Amgen (AMGN) Dipped More Than Broader Market Today
|
|
Jun 6
|
Amgen's (AMGN) Uplizna Meets Study Goal for Rare Disease
|
|
Jun 6
|
Why Is Intra-Cellular (ITCI) Up 1.2% Since Last Earnings Report?
|
|
Jun 6
|
Amgen reports positive data from Phase III IgG4-RD treatment trial
|
|
Jun 5
|
AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
|